🇺🇸 FDA

Intelligence Platform

Patents

Browse 302 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8080584

Delayed release rasagiline citrate formulation

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Dec 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8080672

Crystal form of atorvastatin hemi-calcium and processes for preparation thereof

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Dec 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8071638

Solid states of atorvastatin potassium

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Dec 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8067423

Polymorphs of dasatinib isopropyl alcohol and process for preparation thereof

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Nov 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8067473

Methods for enhancing the therapeutic efficacy of topoisomerase inhibitors

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Nov 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8063211

Rosuvastatin and salts thereof free of rosuvastatin alkylether and a process for the prepa

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Nov 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8063250

Crystal forms of O-desmethylvenlafaxine fumarate

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Nov 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8048222

Highly pure modafinil

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Nov 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8039620

Varenicline tosylate, an intermediate in the preparation process of varenicline L-tartrate

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Oct 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8022190

Immuno-molecules containing viral proteins, compositions thereof and methods of using

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Sep 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8022094

Carvedilol phosphate

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Sep 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7994178

Crystalline rosuvastatin calcium and compositions thereof for treatment of hyperlipidaemia

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7989473

Stable laquinimod preparations

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Aug 02 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7977457

Fusion proteins, uses thereof and processes for producing same

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jul 12 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7973045

Anhydrous form of dasatinib and process for preparation thereof

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jul 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 30 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7968749

Process for preparing and drying solid rasagiline base

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jun 28 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 23 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7968511

Combination therapy with glatiramer acetate and mitoxantrone for the treatment of multiple

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jun 28 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 23 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7964748

Process for preparing intermediates of HMG-CoA reductase inhibitors

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jun 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7960586

Purification of armodafinil

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jun 14 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7923215

Process for the measurement of the potency of glatiramer acetate

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Apr 12 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7915412

Process for the synthesis of 9-hydroxy risperidone (paliperidone)

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Mar 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7915423

Solid states of pantoprazole sodium, processes for preparing them and processes for prepar

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Mar 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7884226

Purification of rosuvatatin intermediate by thin film evaporation and chemical method

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Feb 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7884208

Crystals of laquinimod sodium, and process for the manufacture thereof

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Feb 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted